Shares Outstanding Shares Outstanding n/a Close	586.6M
Shares Change (YoY) Shares Change (YoY) n/a Close	-2.8%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	-0.69%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	84.04%
Shares Floating Shares Floating n/a Close	574.7M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	6,904
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.15%

Short Selling Information

The latest short interest is 5.84M, so 1% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	5.84M
Short % of Shares Out Short % of Shares Out n/a Close	1%
Short % of Float Short % of Float n/a Close	1.13%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	1.15

Valuation Ratios

The PE ratio is 10.6 and the forward PE ratio is 27.33. Edwards Lifesciences's PEG ratio is 0.05.

PE Ratio PE Ratio n/a Close	10.6
Forward PE Forward PE n/a Close	27.33
PS Ratio PS Ratio n/a Close	8.13
Forward PS Forward PS n/a Close	5.1
PB Ratio PB Ratio n/a Close	4.43
P/FCF Ratio P/FCF Ratio n/a Close	152.63
PEG Ratio PEG Ratio n/a Close	0.05

Financial Ratio History

Enterprise Valuation

Edwards Lifesciences has an Enterprise Value (EV) of 41.9B.

EV / Sales EV / Sales n/a Close	7.7
EV / EBITDA EV / EBITDA n/a Close	24.32
EV / EBIT EV / EBIT n/a Close	77.27
EV / FCF EV / FCF n/a Close	144.54

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.07.

Current Ratio Current Ratio n/a Close	4.18
Quick Ratio Quick Ratio n/a Close	3.45
Debt / Equity Debt / Equity n/a Close	0.07
Debt / EBITDA Debt / EBITDA n/a Close	0.41
Debt / FCF Debt / FCF n/a Close	2.41
Interest Coverage Interest Coverage n/a Close	69.63

Financial Efficiency

Return on Equity is 41.75% and Return on Invested Capital is 10.72%.

Return on Equity Return on Equity n/a Close	41.75%
Return on Assets Return on Assets n/a Close	31.98%
Return on Invested Capital Return on Invested Capital n/a Close	10.72%
Revenue Per Employee Revenue Per Employee n/a Close	$344,272.15
Profits Per Employee Profits Per Employee n/a Close	$264,215.19
Employee Count Employee Count n/a Close	15,800
Asset Turnover Asset Turnover n/a Close	0.42
Inventory Turnover Inventory Turnover n/a Close	1.03

Taxes

Income Tax Income Tax n/a Close	152.1M
Effective Tax Rate Effective Tax Rate n/a Close	9.82%

Stock Price Statistics

The stock price has increased by -14% in the last 52 weeks. The beta is 1.12, so Edwards Lifesciences's price volatility has been higher than the market average.

Beta Beta n/a Close	1.12
52-Week Price Change 52-Week Price Change n/a Close	-14%
50-Day Moving Average 50-Day Moving Average n/a Close	74.49
200-Day Moving Average 200-Day Moving Average n/a Close	71.34
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	42.78
Average Volume (20 Days) Average Volume (20 Days) n/a Close	4,628,725

Income Statement

In the last 12 months, Edwards Lifesciences had revenue of 5.44B and earned 4.17B in profits. Earnings per share was 6.98.

Revenue Revenue n/a Close	5.44B
Gross Profit Gross Profit n/a Close	4.32B
Operating Income Operating Income n/a Close	1.38B
Net Income Net Income n/a Close	4.17B
EBITDA EBITDA n/a Close	1.72B
EBIT EBIT n/a Close	1.57B
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	6.98

Full Income Statement

Balance Sheet

The company has 3.05B in cash and 700M in debt, giving a net cash position of 2.35B.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	3.05B
Total Debt Total Debt n/a Close	700M
Net Cash Net Cash n/a Close	2.35B
Retained Earnings Retained Earnings n/a Close	13.17B
Total Assets Total Assets n/a Close	13.06B
Working Capital Working Capital n/a Close	4.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 542.3M and capital expenditures -252.4M, giving a free cash flow of 289.9M.

Operating Cash Flow Operating Cash Flow n/a Close	542.3M
Capital Expenditures Capital Expenditures n/a Close	-252.4M
Free Cash Flow Free Cash Flow n/a Close	289.9M
FCF Per Share FCF Per Share n/a Close	0.49

Full Cash Flow Statement

Margins

Gross margin is 79.46%, with operating and profit margins of 25.35% and 76.75%.

Gross Margin Gross Margin n/a Close	79.46%
Operating Margin Operating Margin n/a Close	25.35%
Pretax Margin Pretax Margin n/a Close	28.46%
Profit Margin Profit Margin n/a Close	76.75%
EBITDA Margin EBITDA Margin n/a Close	31.68%
EBIT Margin EBIT Margin n/a Close	25.35%
FCF Margin FCF Margin n/a Close	5.33%

Dividends & Yields

EW does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	9.43%
FCF Yield FCF Yield n/a Close	0.66%

Dividend Details

Analyst Forecast

The average price target for EW is $79, which is 5.7% higher than the current price. The consensus rating is "Hold".

Price Target Price Target n/a Close	$79
Price Target Difference Price Target Difference n/a Close	5.7%
Analyst Consensus Analyst Consensus n/a Close	Hold
Analyst Count Analyst Count n/a Close	20

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$174.5
Lynch Upside Lynch Upside n/a Close	133.57%
Graham Number Graham Number n/a Close	51.27
Graham Upside Graham Upside n/a Close	-31.37%

Stock Splits

The last stock split was on Jun 1, 2020. It was a forward split with a ratio of 3:1.

Last Split Date Last Split Date n/a Close	Jun 1, 2020
Split Type Split Type n/a Close	forward
Split Ratio Split Ratio n/a Close	3:1

Scores

Altman Z-Score Altman Z-Score n/a Close	11.71
Piotroski F-Score Piotroski F-Score n/a Close	5